Scientists identify mutational signatures in ovarian cancer

NewsGuard 100/100 Score

Researchers at Cancer Research UK, Imperial College London and the University of Cambridge have identified distinct patterns of genetic mutation among patients with ovarian cancer that could help them understand the disease and personalise treatment in the future.

Chromosomes with mutations on dark backgroundImage Credit: Double Brain / Shutterstock

The genetic changes seen in ovarian cancer cells are particularly chaotic, with a scrambled genetic code that has been sliced up, deleted, incorrectly copied or copied too much.

This makes it particularly difficult for researchers to understand what exactly has led to a patient’s cancer and how that patient will respond to therapy.

Now, researcher James Brenton and colleagues have used big data processing techniques to determine patterns of DNA rearrangement in ovarian cancer samples from more than 500 women.

Rather than trying to identify the specifics of individual errors in the DNA, the technique used powerful algorithms that scanned the cancer genomes to look for broad patterns in the genetic arrangement of the cancer cells.

Our study is a turning point for our understanding of the disease as for the first time we can see each patient’s unique combination of mutation patterns and start to identify the genetic causes of a patient’s cancer using cheap DNA testing in the clinic.”

Dr. James Brenton, Lead Researcher

As reported in the journal Nature Genetics, the team found seven distinct patterns or “signatures” that each reflected a different mechanism through which the DNA had become mutated.

All patients expressed more than one of these signatures, suggesting that several mechanisms underly the changes seen in ovarian cancer cells.

This could explain why it is so difficult to beat the cancer using treatments that target just one mechanism.

The signatures were also associated with how well patients responded to therapies and their likelihood of becoming resistant to chemotherapy.

Next, the team intends to conduct a clinical trial to work out how these genetic changes can be targeted with new therapies.

Our new approach helps to decode the complexity and will improve outcomes and treatment choices for our patients.”

Professor Iain McNeish, Co-Author

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2023, July 18). Scientists identify mutational signatures in ovarian cancer. News-Medical. Retrieved on May 18, 2024 from

  • MLA

    Robertson, Sally. "Scientists identify mutational signatures in ovarian cancer". News-Medical. 18 May 2024. <>.

  • Chicago

    Robertson, Sally. "Scientists identify mutational signatures in ovarian cancer". News-Medical. (accessed May 18, 2024).

  • Harvard

    Robertson, Sally. 2023. Scientists identify mutational signatures in ovarian cancer. News-Medical, viewed 18 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.